Safety and efficacy of ponatinib in patients with chronic myeloid leukemia
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2016 New trial record
- 01 Jun 2015 Recruitment completed, according to results presented at the 21th Congress of the European Haematology Association.